FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely, to obstetrics and gynecology, and deals with prevention of fetal congenital malformations. For this purpose in the first term of pregnancy to pregnant woman introduced are water solution of medication "Immunal" in dose 1 dosometric pipette 2 times per day, nicotine acid pills in dose 50 mg 2 times per day, rectal clysters with 30% sodium thiosulfate solutions in dose 5.0 ml and 0.25% solution of novocaine - 15 ml; rekicen RD in dose a dessert spoon two times per day simultaneously daily during 30 days.
EFFECT: empirically selected complex of medications, introduced in devised doses and regimen, ensures efficient prevention of fetal congenital malfunctions without side effects.
4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH REFRACTORY PREGNANCY LOSS IN FIRST TRIMESTER | 2010 |
|
RU2452481C1 |
METHOD OF TREATING THREATENING MISCARRIAGE IN 2-3 TRIMESTER OF PREGNANCY | 2012 |
|
RU2514542C1 |
METHOD FOR PREVENTING PLACENTAL DEFICIENCY UNDER CONDITIONS OF UROGENITAL INFECTING WITH CHLAMYDIOSIS | 2004 |
|
RU2268740C1 |
METHOD FOR PREECLAMPSIA PREVENTION | 2011 |
|
RU2472506C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF CRITICAL CONDITIONS OF WOMEN DURING CHILDBEARING AND DURING THE PUERPERIUM | 2017 |
|
RU2647459C1 |
METHOD FOR PREDICTION OF DEVELOPING SEVERE PREECLAMPSIA | 2012 |
|
RU2481578C1 |
METHOD OF PREDICTING FORMATION OF CONGENITAL DEFECTS OF FETUS DEVELOPMENT IN PREGNANT WOMEN IN FIRST TRIMESTER OF PREGNANCY | 2010 |
|
RU2449283C1 |
METHOD FOR PREPARING AND CONDUCTING THE PREGNANCY IN WOMEN WITH HERPES VIRAL INFECTION | 2005 |
|
RU2283141C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING UNFAVOURABLE MATERNAL OUTCOMES DURING PREGNANCY, CHILDBIRTH AND THE POSTPARTUM PERIOD | 2023 |
|
RU2803129C1 |
METHOD FOR PREDICTING PLACENTAL INSUFFICIENCY IN PRECLINICAL PERIOD | 1999 |
|
RU2148256C1 |
Authors
Dates
2012-11-10—Published
2011-11-07—Filed